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Abstract
Immunoproteasomes, harboring the active site subunits β5i/LMP7, β1i/LMP2, and β2i/
MECL1 exert protective, regulatory or modulating functions during infection-induced
immune responses. Immunoproteasomes are constitutively expressed in hematopoietic
derived cells, constituting the first line of defense against invading pathogens. To clarify the
impact of immunoproteasomes on the innate immune response against Streptococcus
pneumoniae, we characterized the progression of disease and analyzed the systemic
immune response in β5i/LMP7-/- mice. Our data show that β5i/LMP7 deficiency, which
affected the subunit composition of proteasomes in murine macrophages and liver, was
accompanied by reduced transcription of genes encoding immune modulating molecules
such as pentraxins, ficolins, and collectins. The diminished opsonin expression suggested
an impaired humoral immune response against invading pneumococci resulting in an
aggravated systemic dissemination of S. pneumoniae in β5i/LMP7-/- mice. The impaired
bacterial elimination in β5i/LMP7-/- mice was accompanied by an aggravated course of
pneumonia with early mortality as a consequence of critical illness during the late phase of
disease. In summary our results highlight an unsuspected role for immuno-subunits in mod-
ulating the innate immune response to extracellular bacterial infections.
Introduction
The ubiquitin proteasome system (UPS) is the primary non-lysosomal ATP-dependent protein
degradation machinery in eukaryotic cells [1]. By degrading short-lived poly-ubiquitin-tagged
substrates, it determines the availability of regulatory proteins and controls a large number of
physiologically important cellular processes such as gene regulation and inflammatory
response [2]. The 26S proteasome is the central proteolytic enzyme of the UPS. The catalytic
activity is restricted to three β-subunits (β1, β2, and β5) of the 20S proteasome core particle [3].
In response to IFN-γ three alternative proteolytically active β-subunits, β1i/LMP2, β2i/MECL1,
and β5i/LMP7 are incorporated into a nascent 20S proteasome generating a new sub-type,
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named immunoproteasome (i-proteasome) [1]. Constitutive expression of the immuno-sub-
units occurs in hematopoietic derived cells such as splenocytes, macrophages, and dendritic
cells [2]. In comparison to standard proteasomes which are constitutively expressed in all cell
types, i-proteasomes exhibit altered cleavage preferences affecting the versatility of antigen pro-
cessing and the possibility to generate and present immunogenic epitopes onto MHC-class I
molecules [4–6]. Therefore, β5i/LMP7-deficient mice are impaired in i-proteasome formation
or efficient anti-viral and anti-bacterial immune response, as shown for CVB-3 [7] and L.
monocytogenes infection [8], respectively.
However, i-proteasomes not only function by generating MHC-class I epitopes, but also
possess additional immunological functions in connection with inflammatory diseases. For
example, β5i/LMP7-/- mice exhibit an attenuated experimental colitis with no induction of pro-
inflammatory cytokines and reduced intestinal inflammation [9,10]. Moreover, recent human
genetics studies, identifying missense or nonsense mutations in the PSMB8 gene encoding β5i/
LMP7, support the involvement of i-proteasomes in inflammatory disorders [11]. All patients
carrying mutations in the PSMB8 gene suffer from symptoms displaying recurrent fever, ele-
vated levels of acute phase molecules, high levels of IL-6, and auto-immune abnormalities [11].
Several studies underline the role of i-proteasomes in specific pro-inflammatory signaling
pathways, by controlling gene expression of immune modulators or altering the protein turn-
over rate of critical signaling molecules [2,9,12].
Streptococcus pneumoniae is estimated to cause 27% of all cases of community acquired
pneumonia, being the most frequent pathogen causing lower respiratory tract infections [13].
Depending on the serotype S. pneumoniae causes pneumonia, otitis media, meningitis, and
bacteremia [14]. A cohort study estimated the 28-day mortality in patients, hospitalized due to
community acquired pneumonia, to 13% in South America, 9% in Europe, and 7% in North
America [15]. Multiple antibiotic resistance has rapidly increased exerting 21% drug resistance
to clindamycin, 39% to erythromycin, and 21% to oral penicillin according to a US study [16].
Because antibiotic resistance still spreads S. pneumoniae remains a critical pathogen [17].
The immune system employs numerous mechanisms to protect the host from an invasive
pneumococcal infection. Releases of bacterial cell-wall particles, toxins, and DNA initiate acti-
vation of these defense mechanisms via pattern-recognition receptors (PRRs) [18]. They recog-
nize bacterial components containing conserved motifs that are referred to as pathogen-
associated molecular patterns (PAMPs) [19]. PRRs such as TLRs stimulate the production of
NF-κB and AP-1 dependent immune modulating components via the MyD88, TRIM/TRAF,
and MAP kinase pathway resulting in activation of innate immune defenses [18]. Alveolar
macrophages represent the first phagocytic defense and are essential in initiating and coordi-
nating the innate immune response to infection [20]. In addition to phagocytosis and endoso-
mal clearance of S. pneumoniae, they rapidly produce large amounts of pro-inflammatory
cytokines as well as reactive oxygen species. Alveolar macrophages are activated by PAMPs but
also by cytokines, complement, and antibody complexes [21], and finally contribute to the res-
olution of inflammation in lung tissue by clearing apoptotic cells [22]. In established pneumo-
nia, neutrophils become the major cells eliminating bacteria. Chemokines such as CXCL-1
stimulate their chemotaxis [23]. If alveolar defense mechanisms are overwhelmed, invasion of
S. pneumoniae into the bloodstream takes place. Clearance of pneumococci from circulation
strongly depends on opsonization enhancing bacterial phagocytosis by leukocytes [24]. Pen-
traxins are cytokine-inducible soluble PRRs and part of the humoral innate immune system
[25]. They opsonize bacteria and promote phagocytosis by macrophages and neutrophils [26].
They include the short pentraxin C reactive protein (CRP), which is systemically produced in
liver during the acute phase response and the long pentraxin PTX-3 [27]. PTX-3 is produced in
various cell types, with macrophages being one of the major sources. Pentraxins interact with
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opsonizing components (C1q, MBL, and Ficolin) of the classical and lectin activation pathway
of the complement system, thereby amplifying its effector functions [28].
Using β5i/LMP7-/- mice, we studied the impact of i-proteasomes on the innate immune
response against S. pneumoniae. Our experiments revealed that β5i/LMP7 deficiency alters the
composition of proteasomes in murine macrophages and liver, which is accompanied by
reduced gene transcription of immune modulating molecules. Reduced opsonin expression
and impaired bacterial elimination in β5i/LMP7-/- mice is accompanied by a more severe case
of pneumonia with early mortality in consequence of critical illness during the late phase of
disease. Taken together, our findings highlight an unexpected role for i-proteasomes in modu-
lating the innate immune response to extracellular bacterial infections.
Material and Methods
Cell culture experiments
Primary cells were obtained fromWT and β5i/LMP7-/- C57BL/6 (J) mice. The protocol was
approved by the Committee on the Ethics of Animal Experiments of Berlin State authorities
(Landesamt für Gesundheit und Soziales Berlin, approval ID: T0371/11). Cell lines (L929, Raw
264.7) were kindly provided by Prof. Bastian Opitz (Charité Universitätsmedizin Berlin, Berlin,
Germany). Cells were stimulated with LPS (Sigma Aldrich, Hamburg, Germany) and epoxomi-
cin (Merck, Darmstadt, Germany).
Bacterial strains
Streptococcus pneumoniae strain D39Δcps (serotype 2 carrying a deletion mutation in the poly-
saccharide capsule gene) was used in cell culture experiments and S. pneumoniae strain PN36
(serotype 3, NCTC7978) was used to induce pneumonia in in vivo experiments. Bacteria were
grown in THY medium (30% Todd-Hewitt-Bouillion (BD Bioscience, San Jose, CA, USA),
0.5% Yeast (BD Bioscience, San Jose, CA, USA) at 37°C and 5% CO2 until they reached a phase
of logarithmic growth. For heat-inactivation, bacteria where incubated at 56°C for 1 h while
shaking.
Generation and cultivation of bone marrow derived macrophages (BMM)
Bone marrow was isolated by flushing the opened cavity of femur and tibia with RPMI (Bio-
chrom, Berlin, Germany). A single cell suspension was prepared, and incubated over night by
37°C and 5% CO2 in RPMI and 10% FCS (Biochrom, Berlin, Germany) in a cell culture dish.
Non-adherent cells were collected and differentiated in RPMI with 30% L929 supernatant, con-
taining m-CSF, for 9 days.
Phagocytosis assay
BMMwere covered with ice-cold PBS containing heat-inactivated D39Dcps-PKH67 (MOI 25)
and placed on ice for 15 min. Except for the negative control cells, which remained on ice, mac-
rophages were incubated at 37°C for up to 120 min. Finally, cells were placed on ice and
D39Dcps-PKH67 were removed. Cells were washed with ice-cold PBS and harvested. The flo-
rescent intensity of internalized D39Dcps-PKH67 was measured by flow cytometry. Heat-inac-
tivated D39Dcps were fluorescently labeled with PKH67 using PKH67 linker kit (Sigma
Aldrich, Hamburg, Germany).
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Gentamicin protection assay
6×105 or 1×106 BMM were seeded on a 12-or 6-well plate culture dish and co-cultivated with
D39Dcps (MOI 10) without antibiotics at 37°C for 30 min or 4 h. In order to remove remaining
extracellular bacteria, cells were washed with pre-warmed PBS and cultivated further with gen-
tamicin (300 mg/ml or 20 mg/ml) (Lonza, Aboise, France). After an incubation period of sev-
eral hours, cells were washed with PBS and lysed by adding PBS with 0.02% Triton X (Sigma
Aldrich, Hamburg, Germany). Serial dilutions of the supernatant were plated on blood agar
(BD Bioscience, San Jose, CA, USA) and the CFUs were determined.
Indirect measurement of NO
Macrophages were stimulated and the nitrite content of the supernatant determined, using the
Griess Reagent kit for nitrite determination (Molecular Probes, Darmstadt, Germany).
Animal infection experiments
Mice were kept at the animal facilities of the Charité-Universitätsmedizin Berlin, according to
the European and Berlin State guidelines for animal welfare. Mice were bred in a heterozygous
mating. All animal experimental protocols were approved by the Committee on the Ethics of
Animal Experiments of Berlin State authorities (Landesamt für Gesundheit und Soziales Berlin,
approval ID: G0073/11). All analyzed groups contained female littermates with an age of 8–11
weeks exclusively. For infection, mice were anesthetized by intraperitoneal (i.p.) application of
ketamine (80 mg/kg) and xylazine (25 mg/kg) (both Cp pharma, Burgdorf, Germany) and
transnasally inoculated with 7.5×104 or 5×106 CFU S. pneumoniae (PN36) in 20 μl sterile phos-
phate-buffered saline (PBS) as described previously [29]. In uninfected mice, 20 μl PBS/mouse
was transnasally applied as control. Disease severity of infected mice was monitored and docu-
mented every 12 h. Survival was recorded for 10 days post infection. Mice were humanely sacri-
ficed by exsanguination via the Vena cava caudalis after i.p. injection of ketamine (160 mg/kg
body weight) and xylazine (75 mg/kg), when they reached at least one of the predefined
humane endpoints ([(i) body temperature<30°C, (ii) body weight loss 20%, (iii) cumber-
some breathing, (iv) accelerated breathing in combination with staggering, pain or paleness]).
No unexpected cell death was observed in these experiments. For the analysis of blood leuko-
cytes and bacterial burden in lungs and blood 24 or 48 h post infection, anesthetized (160 mg/
kg mg ketamine, 75 mg/kg xylazine) mice were tracheotomised and heparinized. Blood was
taken via the Vena cava caudalis and kept on ice in EDTA-coated tubes. For determination of
bacterial burden in lungs, these were dissected without trachea and main bronchi and minced
by pressing the tissue through a 100 μm cell strainer. Serial dilutions of samples were plated on
blood agar, and CFUs were determined.
Cytokine multiplex assay
Chemokine concentrations in plasma of infected mice were measured by using the Bio-Plex
Pro Mouse Cytokine Group I Assay (Bioplex1, BioRad, Hercules, CA) and the multiplex work-
ing station, provided by the Deutsches Rheuma-Forschungszentrum (DRFZ) Berlin, Germany.
Flow cytometry
For analysis of the cellular immune status, total blood leukocytes were counted by fluores-
cence-activated cell sorter (FACS) analysis (FACS Calibur; BD Biosciences, Heidelberg, Ger-
many) using BD TruCount Tubes (BD Bioscience, San Jose, CA, USA), forward vs. side scatter
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characteristics and antibody staining with CD45-PerCP (clone 30-F11; BD Bioscience, San
Jose, CA, USA), GR-1-PE (clone RB6–8C5; BD Bioscience, San Jose, CA, USA).
Bronchoalveolar lavage in vivo
Mice transnasally infected with 5×106 CFU PN36 were anesthetized 48 h post infection with
ketamine (160 mg/kg body weight (BW)) and xylazine (75 mg/kg BW), tracheotomized and
ventilated as previously described [30]. After heparinization, blood was drawn from the Vena
cava caudalis. Lungs were flushed with sterile 0.9% saline via the pulmonary artery. Afterward,
bronchoalveolar lavage (BAL) was performed twice using 800 μl PBS containing protease
inhibitor each time (Roche, Mannheim, Germany) After centrifugation of both BAL fluids at
800 × g, the supernatants were separately snap frozen. Supernatant of the first BAL was used
for protein and albumin analysis. The amount of murine serum albumin in plasma and BAL
fluid was measured by ELISA according to manufacturer’s protocol (Bethyl, Montgomery, TX,
USA). Protein quantification was performed using BCA protein assay kit (Thermo Fisher Sci-
entific, Waltham, MA USA).
Serological Analysis
The enzyme activity of ALAT and LDH in serum of ill animals was measured by the Institute
of Veterinary Medicine and Diagnostics, Berlin, Germany.
Immuno-blotting
Equal amounts of protein extracts were separated by SDS-PAGE and transferred onto nitrocel-
lulose membranes (Merk, Darmstadt, Germany). I-proteasome subunits were analyzed by
immuno-blotting using anti-mouse anti-β5i/LMP7, anti-β5, anti-β1i/LMP2 (Abcam, Cam-
bridge, UK) and anti-β1, anti-β2i/MECL-1, anti-α4 (self-made), and AP1 components, anti-
(p)-cJun, anti-(p)-cFos, anti-cFos, anti-(p)-ATF-2, anti-ATF-2 (Cell signaling, Leiden, Nether-
lands), and anti-cJun (Santa Cruz Biotechnologie, Dallas, Texas, USA) antibodies combined
with a secondary polyclonal mouse-anti-rabbit-IgG antibody conjugated to horseradish peroxi-
dase (Dianova, Hamburg, Germany). Anti-β-actin antibody (Cell signaling, Leiden, Nether-
lands) was used as loading control.
20S purification and 2D Gel analysis
One billion BMM were pestled in TEAD buffer, using a douncer, and centrifuged for 60 min at
13.000 rpm and 4°C. The resulting supernatant was used for the purification of 20S protea-
somes, as previously described [31]. The purified 20S proteasome was precipitated in ethanol
(96%) overnight at -20°C. Precipitated 20S proteasomes were centrifuged for 60 min at 13.000
rpm and 4°C, and pellets was washed with ethanol (70%). The proteasomes were centrifuged
again for 30 min at 13.000 rpm and 4°C, pellets were dried, and the 2D electrophoresis was car-
ried out by Protalys GmbH, Berlin, Germany.
Quantitative real-time RT-PCR
Total RNA was extracted using Trizol-Chlorophorm extraction (Invitrogen, Darmstadt, Ger-
many) from cells and pestled tissue followed by reverse transcription using cDNA generation
kit (Roche, Penzberg, Germany). The cDNA was used for PCR amplification with the light
cycler instrument (Rotor gene 3000 cycler, Corbett Research) and a TaqMan Real Time Mas-
termix (Applied Biosystems, Darmstadt, Germany) with the following TaqMan probes
(Applied Biosystems, Darmstadt, Germany): Saa1 (Mm01545399_m11), Mbl2
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(Mm0087623_m1), C1qa (Mm00432142), Ptx3 (Mm00477268_m1), Fcna
(Mm00484287_m1), PAFR (Mm02621061_m1) and IL-1-β (Mm00434228_m1). Gene expres-
sion was normalized to the housekeeping gene HPRT1 (Mm01545399_m1) by means of the
ΔCt method.
Statistics
The statistical significance was determined by using the Mann-Whitney U Test for in vivo as
well as ex vivo data and by using the Student t-test for in vitro generated data. All statistical
analyses were performed using GraphPad Prism Software (version 4.03) (GraphPad, San
Diego, CA, USA). Statistical significance was achieved when p<0.05; p<0.05, p<0.01,
p<0.001.
Results
β5i/LMP7 deficiency aggravates clinical signs of pneumococcal
pneumonia
To illustrate the role of i-proteasomes in host defense during S. pneumoniae infection, we
examined the impact of β5i/LMP7 deficiency on the clinical course of pneumococcal pneumo-
nia. Infected animals developed a hypodynamic state, associated with a gradual loss in body
weight from 24 h to 48 h of infection (Fig 1A). The body weight loss was significantly stronger
in β5i/LMP7-/- compared to WT animals. High levels of acute phase proteins accurately corre-
late with the presence and severity of infection, and thus, are commonly used as diagnostic
marker for the extent and outcome of infection [32]. The major acute phase protein, synthe-
sized in mice, is serum amyloid A (SAA) [33]. The expression of saa1 started at 24 h of infec-
tion and increased further over time during the late phase of pneumonia, in both mouse
strains, though much stronger and only significant in β5i/LMP7-/- mice (Fig 1B). In order to
investigate whether β5i/LMP7 is crucial for survival of pneumococcal pneumonia, β5i/LMP7-/-
and WT mice were monitored for their ability to resist to infection (Fig 1C). Although no dif-
ference in the overall approximate survival rate was observed between WT and β5i/LMP7-/-
mice, mice deficient in the β5i/LMP7 subunit and hence in fully functional i-proteasomes died
at earlier time points with an enhanced mortality during the first 108 h of infection, showing
an approximate death rate of about 12% in WT versus about 23.5% in β5i/LMP7-/- mice. Alto-
gether, the aggravated loss in body weight, the more pronounced expression of saa1 and the
premature mortality pointed to an aggravated course of pneumonia in β5i/LMP7-/- mice espe-
cially during the later phase of the disease (48 h post infection).
β5i/LMP7-/- but not WT mice develop sepsis
To validate the influence of β5i/LMP7 deficiency on the severity of the systemic inflammatory
response, we next quantified and discriminated the levels of circulating immune cells 24 h and
48 h post infection (Fig 2A). A significant recruitment of granulocytes was detected in both
mouse strains 24 h post infection that further augmented to an approximate 3.5-fold increase
in WT animals. In contrast, in β5i/LMP7-/- mice, the recruitment of granulocytes diminished
to an approximate 1.3-fold difference at 48 h of infection. Throughout the whole experiment,
levels of leukocytes remained unaffected in WT animals after infection, whereas their numbers
significantly declined in β5i/LMP7-/- mice. At 24 h of infection, the amount of circulating leu-
kocytes decreased by about 35% compared to uninfected control littermates. After 48 h of
infection β5i/LMP7-/- mice exhibited significantly less leukocytes compared to WT animals.
The prominent leukopenia was established by a significant lymphopenia. At 24 h of infection,
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reduced levels of circulating lymphocytes were detected in both mouse strains. However, at the
48 h time point, the total number of lymphocytes decreased even further in β5i/LMP7-/- ani-
mals, establishing a significant difference between infected WT and β5i/LMP7-/- animals. A
correlation analysis between body weight, as indicator of health, and amount of lymphocytes
showed its association with severity of disease (Fig 2B). A severe sepsis is defined by a severe
systemic inflammatory response that is accompanied by peripheral tissue injuries [34]. In
order to assess tissue damage, we evaluated serum levels of the enzyme lactate dehydrogenase
(LDH), which is generally released as a result of cell destruction. Only β5i/LMP7-/- animals
exhibited substantial LDH serum levels after 48 h of infection (Fig 2C). Besides, the strong
recruitment of granulocytes at 24 h of infection suggested a prominent systemic immune
Fig 1. β5i/LMP7-/- mice suffer more thanWTmice from severe pneumonia. (A) Monitoring of body weight 24 h and 48 h after transnasal application of
5×106 CFU PN36/mouse (each group with n = 12–29). (B) Analysis of mRNA expression of the acute phase protein SAA in liver after transnasal application
of 5×106 CFU PN36/mouse, performed by RT and Real Time PCR (each group with n = 3–14) (statistical analysis by MannWhitney U Test. *p<0.05;
**p<0.01; ***p<0.001). (C) Assessment of the approximate survival rate for up to 10 days upon transnasal application of 7.5x104 CFU PN36/mouse (each
group with n = 17).
doi:10.1371/journal.pone.0153847.g001
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reaction. As indicated by a depletion of circulating leukocytes (lymphocytes, granulocytes), this
was accompanied by relative systemic immune suppression at 48 h of infection in β5i/LMP7-/-
animals. Thus β5i/LMP7 deficiency and hence i-proteasome deficiency resulted in a progressed
systemic inflammatory response.
Fig 2. β5i/LMP7-/- mice suffer from a systemic inflammatory response. (A) Determination of blood leukocytes, analyzed by flow cytometry 24 h and 48 h
after application of 5×106 CFU PN36/mouse. As control, 20 μl PBS/mouse was applied transnasally (each group with n = 4–10; statistical analysis by Mann
Whitney U Test. *p<0.05; **p<0.01; ***p<0.001). (B) Correlation of lymphopenia and disease severity, indicated by body weight. Lymphocytes were
detected by FACS analysis 48 h after application of 5×106 CFU PN36/mouse (each group with n = 9–10, statistical analysis by Pearson’s Correlation.
***p<0.001). (C) Documentation of tissue damage 48 h post infection by measuring LDH activity in serum of mice, transnasally infected with 5×106 CFU
PN36/mouse (each group with n = 6–7) (statistical analysis by MannWhitney U Test. *p<0.05; **p<0.01; ***p<0.001).
doi:10.1371/journal.pone.0153847.g002
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Because CXCL-1 and G-CSF plasma levels, which promote development and recruitment of
granulocytes, were almost identical in both mouse strains, we reasoned that the lack of chemo-
kines was not the cause for the reduced neutrophil enrolment (Fig 3).
β5i/LMP7 deficiency aggravates bacteremia during the late phase of
pneumonia
We next assessed the extent of bacterial growth in lung and determined the magnitude of bac-
terial dissemination. Within the first 24 h of infection a considerable proliferation of S. pneu-
moniae was documented in lungs of both mouse strains (Fig 4A) reaching extremely high
numbers. Between 24 h and 48 h of infection, proliferation continued with β5i/LMP7-/- mice
exhibiting a higher bacterial load than infected WT animals. However, due to high variations
this difference did not reach statistical significance. Indeed, hemocultures started to become
positive after 24 h of infection and after 48 h of infection nearly 100% of all WT and β5i/
LMP7-/- animals established bacteremia (Fig 4B). On the contrary, during the late phase of
Fig 3. Systemic levels of chemokines increase after infection, but do not differ betweenWT and β5i/LMP7-/- mice.Determination of chemokines in
plasma, obtained 48 h after transnasal application of 5×106 CFU PN36/mouse, and measured by cytokine multiplex assay (each group with n = 5–7).
doi:10.1371/journal.pone.0153847.g003
Fig 4. β5i/LMP7 deficiency is accompanied by an elevated bacterial load. Determination of bacterial load
24 h and 48 h post infection in (A) lung and (B) blood of mice, transnasally infected with 5×106 CFU PN36/
mouse (each group with n = 9–10; statistical analysis by MannWhitney U Test. *p<0.05).
doi:10.1371/journal.pone.0153847.g004
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pneumonia, at 48 h of infection, β5i/LMP7-/- mice showed an exacerbated bacterial dissemina-
tion, as evidenced by a significantly higher bacterial load in blood compared to WT animals.
Because the airway epithelial platelet-activating factor receptor (PAFR) has been reported to
facilitate invasion of S. pneumoniae to the bloodstream by interacting with bacterial phosphor-
ylcholine [35,36], we next asked whether its expression was altered in β5i/LMP7-/- animals. As
shown in S1 Fig, the up-regulation of PAFR upon infection was significantly less pronounced
in β5i/LMP7-/- mice than in their WT counterparts. These data therefore suggest that the
higher number of pneumococci observed in the blood system of β5i/LMP7-deficient mice is
unlikely to be due to increased invasion of S. pneumoniae through PAFR.
Pneumococcal dissemination is known to be facilitated by serious damage of the alveolar
endo-epithelial barrier. However, detection of endo-epithelial cell damage as assessed by deter-
mining protein concentration in BAL fluid 48 h after transnasal application of 5×106 CFU
PN36/mouse and evaluation of endo-epithelial barrier disruption by measuring concentrations
of serum albumin in BAL fluid 48 h after transnasal application of 5×106 CFU PN36/mouse
did not provide any evidence for an aggravated endo-epithelial disruption due to β5i/LMP7
deficiency, as indicated by the protein and serum albumin content in BAL fluid of infected ani-
mals (Fig 5A and 5B).
The efficiency to kill S. pneumoniae is unaffected in β5i/LMP7-/-
leukocytes
Because β5i/LMP7-/- mice exhibited a higher bacterial load in blood, we investigated the impact
of β5i/LMP7 deficiency on leukocyte function and their ability to eliminate S. pneumoniae. To
analyze phagocytosis efficiency, bone marrow derived macrophages (BMM) were incubated
with fluorochrome-labelled heat-inactivated pneumococci. FACS analysis revealed no differ-
ence in the amount of WT and β5i/LMP7-/- BMM, having incorporated these particles
(Fig 6A). Co-cultivating macrophages with pneumococci showed that β5i/LMP7 deficiency
had no impact on intracellular killing efficiency. Macrophages of both WT and β5i/LMP7-/-
mice effectively eliminated S. pneumoniae in the early and late phase of intracellular killing
Fig 5. Pulmonary infection provokes oedema in lungs of β5i/LMP7-/- andWTmice. (A) Detection of endo-epithelial cell damage, assessed by
determining protein concentration in BAL fluid, obtained 48 h after transnasal application of 5×106 CFU PN36/mouse, and performed by BCA (each group
with n = 7–8). (B) Evaluation of endo-epithelial barrier disruption by measuring concentrations of serum albumin in BAL fluid, obtained 48 h after transnasal
application of 5×106 CFU PN36/mouse by ELISA (each group with n = 7–8).
doi:10.1371/journal.pone.0153847.g005
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(Fig 6B and 6C). Extracellular killing is facilitated by reactive nitrogen species, mainly nitric
oxide (NO), which is for example produced by macrophages expressing iNOS. Mice deficient
for iNOS are highly susceptible to systemic infection and suffer from increased bacteremia
[37]. To investigate the capacity of WT and β5i/LMP7-/- BMM of producing NO, we stimulated
BMM with LPS or heat-inactivated S. pneumoniae, and determined the production of reactive
nitrogen species indirectly by measuring NO2
- levels in supernatant. At 36 h and 48 h of stimu-
lation, elevated NO2
- levels were detected in both mouse groups. However, β5i/LMP7-/- BMM
accumulated less NO2
- compared to WT BMM upon stimulation (Fig 6D), suggesting that β5i/
LMP7 deficiency impairs NO production. However, it was not possible to establish a relation-
ship between decreased NO release and bacterial counts in tissue or blood, since no NO2
- level
above the background value was detected in BAL fluid of WT or β5i/LMP7-/- mice (data not
shown).
β5i/LMP7 deficiency diminishes expression of opsonizing molecules
Because bacterial opsonization results in facilitated pathogen recognition, enhanced phagocy-
tosis, and elimination, we next sought to assess the expression of various opsonizing molecules
in lung and liver of infected animals. In lungs, we examined mRNA expression of collectins
and pentraxins, including C1q (c1qa), and PTX-3 (ptx3) (Fig 7A). At 48 h of infection, the
expression of c1qa and ptx3 was significantly induced in WT animals. By contrast, β5i/LMP7-/-
Fig 6. Efficiency of bacterial killing is unaltered in β5i/LMP7-/- leukocytes. (A) Analysis of phagocytosis of fluorochrome-labelled particles by BMM,
determined by flow cytometry (each group with n = 3). (B) Analysis of the intracellular early phase of killing and (C) late phase of killing of D39Δcps by BMM.
Therefore, BMM were co-cultivated with D39Δcps MOI 10, cells were lysed, and cfu/ml were determined (each group with n = 3). (D) Analysis of NO secretion
byWT and β5i/LMP7-/- BMM, stimulated either with LPS (1 μg/ml) or heat-inactivated D39Δcps lysate (MOI 50). NO concentrations were photometrically
determined in the supernatant by Griess-Reagent (each group with n = 7; statistical analysis by student´s t-test. * p<0.05).
doi:10.1371/journal.pone.0153847.g006
Proteasomes in Innate Immunity
PLOS ONE | DOI:10.1371/journal.pone.0153847 April 21, 2016 11 / 22
mice hardly exhibited any up-regulation of these genes. These in vivo data were confirmed by
in vitro experiments, in which WT and β5i/LMP7-/- macrophages were co-cultivated with S.
pneumoniae. Ptx3 expression was significantly induced upon infection in both mouse groups,
although to a substantially smaller extent in β5i/LMP7-/- macrophages (Fig 7B). Because β5i/
Fig 7. β5i/LMP7-/- mice exhibit a diminished expression of opsonizing molecules in lung, liver andmacrophages. (A) Gene expression analysis of
lungs, 48 h after transnasal application of 5×106 CFU PN36/mouse, performed by RT and Real Time PCR (each group with n = 5–6; statistical analysis by
MannWhitney U Test. *p<0.05). (B) Gene expression analysis of BMM co-cultivated with D39Δcps (MOI 10) for 4 h, performed by RT and Real Time PCR
(each group with n = 4, illustrated experiment is representative for 4 individual replicates; showing mean± SD; statistical analysis by student’s t-test
**p<0.01). (C) Gene expression analysis of liver 48 h after transnasal application of 5×106 CFU PN36/mouse, performed by RT and Real Time PCR (each
group with n = 12–14; statistical analysis by MannWhitney U Test. *p<0.05; **p<0.01).
doi:10.1371/journal.pone.0153847.g007
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LMP7-/- mice suffered from enhanced bacterial growth in blood, we also investigated mRNA
expression of circulating collectins, ficolins, and pentraxins, including mannose binding lectin
MBL (mbl2), c-reactive protein CRP (crp), C1q (c1qa), and Ficolin A (fcna), in the liver of
infected WT and β5i/LMP7-/- mice (Fig 7C).
At 48 h of infection a significant decline in MBL mRNA levels was detected, which was sig-
nificantly more pronounced in β5i/LMP7-/- mice. Similarly, fcna expression was also signifi-
cantly down-regulated only in β5i/LMP7-/- animals. In contrast, expression of C1q mRNA
hardly increased in β5i/LMP7-/- mice but was up-regulated in WT animals. CRP mRNA levels
were significantly increased in both mouse strains, albeit to a weaker extent in β5i/LMP7-/- ani-
mals. The reduced CRP expression was not the consequence of low cytokine stimulation
because IL-6 levels were at equal levels in WT and β5i/LMP7-/- mice (Fig 3). Furthermore, anal-
ysis of the activity of caspase 3/7 in cell lysate and LDH in supernatant of stimulated BMM that
were co-cultivated with D39Δcps for 4h or treated with 10 μMMG132 for 24 h as positive con-
trol (Fig 8A) as well as analysis of potential liver damage, 48 h post infection, by measuring
ALAT activity in serum of mice transnasally infected with 5×106 CFU PN36/mouse (Fig 8B)
revealed that deficiency in β5i/LMP7 did not exacerbate inflammation-induced apoptosis or
cytotoxicity in liver or macrophages.
β5i/LMP7 deficiency alters proteasome subunit composition
independent of infection in liver and macrophages
Because the observed diminished expression of the investigated opsonizing molecules in liver,
lung, and macrophages of β5i/LMP7-/- mice upon S. pneumoniae infection or co-cultivation
was not the consequence of cytotoxic effects, we next asked whether it was the result of protea-
some affected gene regulation provoked by altered proteasome function in consequence of
changes in proteasome composition [9,12]. In agreement with previous reports [38–40], analy-
sis of the proteasome subunit expression by immuno-blotting revealed that in WT liver, in
addition to the β1 and β2 standard subunits, all three immuno-subunits were expressed
(Fig 9A). We failed to detect substantial protein levels of the β5 standard subunit, suggesting
that the liver of WT mice contains mixed-type proteasomes bearing the β5i/LMP7 subunit
together with one or two of the β1 and/or β2 standard subunits. In the liver of β5i/LMP7-/-
Fig 8. β5i/LMP7 deficiency has no apoptotic or cytotoxic effect upon infection. (A) Analysis of the activity of caspase 3/7 in cell lysate and LDH in
supernatant of stimulated BMM. They were co-cultivated with D39Δcps (MOI 10) for 4 h, or treated with 10 μMMG132 for 24 h as positive control (each group
with n = 4). (B) Analysis of potential liver damage, 48 h post infection, by measuring ALAT activity in serum of mice transnasally infected with 5×106 CFU
PN36/mouse (each group with n = 5–6).
doi:10.1371/journal.pone.0153847.g008
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mice, standard β5-subunit levels were detectable whereas the amount of the β1-subunit
remained unchanged. In line with the importance of β5i/LMP7 for i-proteasome assembly, liv-
ers of β5i/LMP7-/- mice revealed weaker signals for β1i/LMP2 and β2i/MECL-1. However, as
indicated by the equal levels of the α4 subunit in WT and β5i/LMP7-/- mice, the overall amount
of proteasomes did not change upon β5i/LMP7 deficiency. Importantly, and as indicated by
unaltered signals for all analyzed β-subunits, infection neither changed the proteasome subunit
composition in WT nor in β5i/LMP7-/- liver. Similar results were obtained by screening the
subunit protein expression in uninfected BMM (Fig 9B). These results suggested that in macro-
phages or hepatocytes the diminished expression of immune modulators was associated to the
absence of β5i/LMP7 and, namely, with reduced levels of i-proteasomes. To thoroughly study
the influence of β5i/LMP7 deficiency in more detail, we analyzed proteasome subunit composi-
tion by 2D gel electrophoresis of purified 20S BMM proteasomes (Fig 9C). As shown in Fig 9D,
WT macrophages assembled immuno- and standard subunits, whereas β5i/LMP7-/- macro-
phages mainly exhibited standard proteasomes. Densitometrical analysis of β5 and β5i/LMP7
protein spots showed that macrophages expressed approximately 40% β5 and approximately
60% β5i/LMP7. In β5i/LMP7-/- 20S proteasomes, the lack of the β5i/LMP7 protein was accom-
panied by an increased incorporation of the standard β5-subunit. In agreement with previous
reports [41], the absence of β5i/LMP7 had a negative impact on the amount of β1i/LMP2 and
β2i/MECL-1 subunits whose incorporation into 20S proteasomes was markedly reduced
(Fig 9D). Both of the WT and β5i/LMP7-/- BMM proteasomes presented equal tryptic- and
Fig 9. Both immuno- and standard subunits of the proteasome are constitutively expressed in leukocytes and liver. (A) Analysis of proteasome
catalytic β-subunits expression on protein level in liver, 48 h after transnasal application of 5×106 CFU PN36/mouse, performed by immuno-blot. (B) Analysis
of proteasome catalytic β-subunits expression on protein level in BMM performed by immuno-blot (each group with n = 3). (C) 2D gel electrophoresis of
purified 20S proteasomes, isolated fromWT BMM. Proteasome subunits were visualized by coomassie stain. (D) Determination of β-subunits, incorporated
in BMM 20S, detected by immuno-blot.
doi:10.1371/journal.pone.0153847.g009
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caspase-like activities (S2 Fig), thereby confirming that the amounts of 20S complexes between
samples were similar. By contrast, the chymotryptic-like activity of β5i/LMP7-/- BMM protea-
somes was by far superior to that detected in WT BMM proteasomes (S2 Fig). This is, however,
in line with previous work showing that β5i/LMP7 deficiency results in an approximately
3-fold increase of the Suc-LLVY-MCA hydrolyzing activity [42].
Deficiency in β5i/LMP7 is accompanied by modified intracellular
signaling in stimulated macrophages
Co-cultivation of epithelial cell with S. pneumoniae results in the induction of the MAP kinase
pathway. This consequently initiates the phosphorylation and activation of the nuclear factor
AP-1 regulating transcription of immune modulatory genes [43]. To study the influence of β5i/
LMP7 deficiency on AP-1 activation we investigated its components, cJun, cFos, and ATF-2,
together with their phosphorylated forms in LPS stimulated or S. pneumoniae co-cultivated
BMM by immuno-blot (Fig 10A and 10B). LPS stimulation or S. pneumoniae exposure resulted
in a robust phosphorylation of cJun, cFos, and ATF-2, which was more pronounced in β5i/
LMP7-/- macrophages compared to WT macrophages. Even in the absence of stimulation, β5i/
LMP7-/- macrophages expressed higher levels of phosphorylated and unphosphorylated cJun,
cFos, and ATF-2 than their WT counterparts. Upon pathogen recognition, the protein expres-
sion of all three AP-1 components was up-regulated in macrophages of both genotypes. Of
note, inhibition of proteasomes by epoxomicin resulted in AP-1 activation following
Fig 10. β5i/LMP7 deficiency as well as proteasome inhibition enhances AP-1 activation in stimulatedmacrophages. (A-B) Immuno-blot on
phosphorylated and non-phosphorylated members of AP-1 and the NF-κB activating pathway in WT and β5i/LMP7-/- BMM, stimulated in vitro for 0 min, 30
min, and 240 min with (A) LPS (1 μg/ml) or (B) D39Δcps (MOI 10) (each group with n = 3). (C) Immuno-blot on phosphorylated and non-phosphorylated cJun
in RAW 264.7 cells, pretreated with DMSO or epoxomicin (250 nM) for 2 h, and subsequently stimulated with LPS (1 μg/ml) or D39Δcps (MOI 10) for 0 h, 2 h,
4 h, and 6 h. (D) Immuno-blot on catalytic β-subunits of the proteasome in RAW 264.7 cells incubated for 2 h with DMSO or epoxomicin (250 nM). Molecular
shift indicates inhibitor binding.
doi:10.1371/journal.pone.0153847.g010
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stimulation of macrophages (Fig 10C). In this experiment, epoxomicin mainly inhibited the
chymotrypsin-like activity of the proteasome by binding to β5, β5i/LMP7, and β1i/LMP2, but
not to β1 and β2i/MECL-1, as indicated by a molecular upward shift in immuno-blot (Fig
10D). Macrophages, treated with epoxomicin, exhibited an enhanced protein level of cJun
exposing a stronger phosphorylation signal. Following LPS stimulation or S. pneumoniae co-
cultivation cJun protein expression and phosphorylation was induced, albeit to a more pro-
nounced extent in epoxomicin pretreated cells. As previously reported [44], proteasome inhibi-
tion was accompanied by a reduced capacity of these cells to induce IL-1-β gene expression in
response to LPS (S3 Fig). Likewise, epoxomicin-treated RAW 264.7 cells showed a much stron-
ger down-regulation of fcna following LPS stimulation than those exposed to DMSO (S3 Fig).
This is in line with our previous observation that β5i/LMP7 deficiency aggravates the drop of
fcnamRNA levels upon infection (Fig 7C). These results suggest that changes in proteasome
composition or inhibition had an effect on transcription factor activation which, in turn, influ-
ences opsonin gene expression.
Discussion
The S. pneumoniae infection model used in this study is a model of untreated fatal pneumonia.
Macrophages, neutrophils, and lymphocytes failed to clear pneumococci, which proliferated
and induced bacteremia in addition to the initial pulmonary infection. All mice developed a
sequential pathogenesis with a lethal outcome. However, mice deficient in the β5i/LMP7 sub-
unit and hence in fully functional i-proteasomes developed an aggravated systemic inflamma-
tory response with enhanced bacteremia likely due to a diminished expression of opsonizing
molecules.
Clinical signs and diagnostic markers, such as body weight loss and SAA expression were
significantly more prominent in β5i/LMP7-/- animals, suggesting a more severe course of pneu-
mococcal disease with critical illness [32]. Although, there was no difference in the overall
approximate survival rate between infected WT and β5i/LMP7-/- mice, the latter showed a
markedly aggravated pneumococcal pneumonia with an advanced chronology of microbiolog-
ical and immunological processes. β5i/LMP7 deficient mice developed a state of relative sys-
temic immune suppression during the late phase of pneumonia, with reduced amounts of
circulating granulocytes. In addition, the total amount of leukocytes significantly declined in
β5i/LMP7-/- mice resulting in prominent leukopenia. This was established by a significant lym-
phopenia and correlated with the magnitude of illness. Our results are in line with previous
reports that defined the final pathogenesis step of a fatal pneumococcal pneumonia with a sys-
temic inflammatory response syndrome which transits into a relative systemic immune sup-
pression, manifested by decreased levels of circulating leukocytes including neutrophils and
lymphocytes [45].
β5i/LMP7-/- mice developed a significantly increased pneumococcal burden in blood during
the late phase of pneumonia. Although intracellular killing properties were not affected in β5i/
LMP7-/- leukocytes, S. pneumoniae stimulated β5i/LMP7-/- macrophages released reduced lev-
els of NO, which is known to control pneumococcal viability [37]. These results are in accor-
dance with those of Reis et al., reporting diminished NO production in β5i/LMP7-/-
macrophages stimulated with LPS [46]. Although Bergeron et al. documented a sustained
release of NO in BAL fluid during the late phase of pneumonia [45], we were not able to detect
NO release in BAL fluid of either WT or β5i/LMP7-/- mice, and thus were not able to demon-
strate a relationship between NO release and bacterial burden.
Opsonizing molecules such as pentraxins and complement components are known to pro-
mote elimination of invading bacteria [47]. Our data show that infection was accompanied by
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the up-regulation of c1qa and ptx3 as well as the down-regulation ofmbl2 (Fig 7). Remarkably,
the induction ptx3 gene expression was significantly less pronounced in β5i/LMP7-/- mice than
inWT animals, while the decreased expression ofmbl2 was more prominent in β5i/LMP7-defi-
cient mice, when compared to their WT littermates. In addition, fcna was found to be substan-
tially repressed following infection in β5i/LMP7-/- mice but not in WT animals. Altogether,
these data highlight the fact that the amount of opsonizing molecules during infection is far
more limited in β5i/LMP7-/- mice. The observation that β5i/LMP7-/- mice exhibit an aggra-
vated systemic dissemination of S. pneumoniae upon infection is in full agreement with the
observed pathological phenotypes of infected opsonin deficient individuals. PTX3-/- mice were
highly susceptible towards lung infection with Pseudomonas aeruginosa [48]. In animal mod-
els, human CRP protects against a lethal infection with S. pneumoniae, and in humans, it con-
tributes to host defense during bacteremic pneumonia [49]. The C1q-mediated complement
activation pathway was shown to be required for an effective innate immune response against
S. pneumoniae [50]. Ficolin A is thought to be the key recognition component of the lectin acti-
vation pathway, essential for an effective host defense against pneumococcal infection [51].
Furthermore, patients, homozygotes for an MBL codon variant exhibited reduced MBL serum
levels and were highly susceptible to invasive pneumococcal infections [26]. Surprisingly, the
induction of PAFR during infection with S. pneumoniae was slightly impaired in β5i/LMP7-/-
mice (S1 Fig). Given the role of PAFR as a virulence factor receptor, a decreased susceptibility
of the animals could result, which is not the case. However, this apparent discordance can be
easily explained by the fact that β5i/LMP7-/- mice express substantially less opsonizing mole-
cules which may overcome the potential beneficial effect of decreased expression of PAFR on
the disease.
Importantly, Weber et al. have shown that the transporter with antigen processing (TAP)
and the β2-microglobulin (β2-m) were dispensable for the clearance of S. pneumoniae [52].
This suggests that MHC class I antigen processing and presentation is not required in this pro-
cess and underscores the importance of the β5i/LMP7 subunit in innate immunity in the con-
text of S. pneumoniae infection by regulating gene expression of critical mediators including
opsonins. The β5i/LMP7 subunit deficiency has a substantial impact on the assembly and com-
position of proteasomes in cells constitutively expressing or up-regulating i-proteasomes.
Changes in the cellular proteasome sub-type composition lead to altered proteasomal activities
affecting cell and tissue functions during infection and inflammation [7–9,12,53]. In our S.
pneumoniae infection model, the altered proteasome composition and its presumably impaired
function in macrophages and liver of β5i/LMP7-/- mice coincided with affected gene transcrip-
tion of immune modulating molecules. It has been shown that β5i/LMP7 deficiency negatively
affects the incorporation of β1i/LMP2 and β2i/MECL1 and hence the overall proteasome sub-
type composition of cells [41]. Dahlmann et al. showed that different proteasome sub-types
exhibited altered enzymatic properties, differing in their substrate degradation rate and in the
quality of generated products [6]. In fact, the presence and absence of the β5i/LMP7 subunit in
20S proteasomes was shown to affect the structure as well as the function of proteasomes
[5,54]. Therefore, it is conceivable that different proteasome sub-types may influence gene
transcription by differentially degrading specific proteins of intracellular signaling cascades or
by degrading regulatory molecules that either inhibit or activate gene transcription.
The role of proteasomes and i-proteasomes in the regulation of pro-inflammatory cytokines
via NF-κB is well described [7,9,12,53]. Here, we analyzed the effect of i-proteasome deficiency
on the S. pneumoniae induced activation of AP-1 which is believed to regulate inflammatory-
mediated gene transcription [19]. Gerber et al. reported that proteasome inhibition induced
MAPK activation and subsequent cJun-dependent AP-1 activity in monocytes [55]. Our exper-
iments showed that β5i/LMP7 deficiency confers an enhanced effect on AP-1 activation. This
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suggests that structural changes induced on the proteasome complex due to β5i/LMP7 defi-
ciency which concomitantly influence the proteolytic properties of the proteasome most likely
alter signaling pathways. Enhanced AP-1 activation may be the consequence of diminished
degradation of up-stream kinases, such as IRAK-1 or MAPKs [56]. Because i-proteasomes
have an enhanced ability to degrade oxidized, misfolded, and poly-ubiquitinated proteins [7],
it is also conceivable that AP-1 activation may be facilitated by enhanced proteotoxic and oxi-
dative stress due to β5i/LMP7 deficiency [57].
Pathogen activated signaling pathways are complex and numerous nuclear factors have
been demonstrated to play critical roles in the subsequent expression of inflammatory media-
tors. However, regarding the complexity of the intracellular signaling, redundancy among sig-
naling cascades, influencing and compensating each other, is likely. It is therefore difficult to
clarify a specific impact of β5i/LMP7 deficiency on gene regulation. However, the regulated
diversity of proteasome sub-types is most likely important to precisely adjust endogenous cell
signaling and activity of transcription factors adapted for cell specific functions.
In conclusion, the absence of the catalytic immuno-subunit β5i/LMP7 in murine macro-
phages and liver tissue changes the composition of their proteasomes that may have modified
pathogen induced intracellular signaling pathways resulting in reduced gene transcription of
immune modulating molecules. In our study, opsonins are prime examples of immune mole-
cules whose expression is substantially impaired following infection in i-proteasomes-free
mice. The diminished opsonin expression may result in an aggravated systemic dissemination
of S. pneumoniae in β5i/LMP7-/- mice. The impaired bacterial elimination is accompanied by
aggravated pneumonia with early mortality in consequence of critical illness during the late
phase of disease.
Supporting Information
S1 Fig. β5i/LMP7 deficiency diminishes PAFR induction upon infection with S. pneumo-
niae. PAFR gene expression analysis of lungs, 48 h after transnasal application of PBS or 5x106
CFU PN36/mouse, as indicated and performed by real-time PCR (each group with n = 5–8;
statistical analysis by Student’s t test. p<0.05 and p<0.001). The amount of transcripts for
each gene was normalized to the HPRT1 housekeeping gene. Given are the ΔCtmeasured val-
ues.
(TIF)
S2 Fig. Enzymatic activities of BMM 20S proteasomes isolated from wild-type and β5i/
LMP7-/- mice.One hundred and twenty five nanograms of purified BMM 20S proteasomes
isolated from wild-type and β5i/LMP7 mice was incubated with each of the Suc-LLVY-AMC
(100 μM, chymotryptic-like), Bz-VGR-AMC (200 μM) and z-LLE-AMC (200 μM) to monitor
the chymotryptic-, tryptic- and caspase-like activity, respectively. After 40 min of incubation at
37°C, the plates were read at an absorption/emission of 360/460 using a microplate fluores-
cence reader. Shown is one representative experiment out of three: p<0.05 (Student’s t-
test).
(TIF)
S3 Fig. Proteasome inhibition is accompanied by decreased expression of fcna in RAW
cells following LPS stimulation. RAW 264.7 cells were subjected to a 2-h treatment with 250
nM epoxomicin (or DMSO as a control) prior to a stimulation with 1 μg/ml LPS for 24 h. Cells
were collected at 0, 2, 4, 6, 8 and 24 h post-stimulation for RNA extraction. One microgram of
total RNA was used for reverse transcription (RT) and quantitative PCR analysis of IL-1-β and
fcna, as indicated. After real-time PCR, the amount of transcripts for each gene was normalized
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to the HPRT1 housekeeping gene. Given are the ΔCtmeasured values. One representative
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